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Abstract
Excitotoxic damage represents the major mechanism leading to cell death in many
human neurodegenerative diseases such as ischemia, trauma and epilepsy.
Caused by an excess of glutamate that acts on metabotropic and ionotropic
excitatory receptors, excitotoxicity activates several death signaling pathways
leading to an extensive neuronal loss and a consequent strong activation of
astrogliosis. Currently, the search for a neuroprotective strategy is aimed to identify
the level in the signaling pathways to block excitotoxicity avoiding the loss of
important physiological functions and side effects. To this aim, PTEN can be
considered an ideal candidate: downstream the excitatory receptors activated in
excitotoxicity (whose inhibition was shown to be not clinically viable), it is involved in
neuronal damage and in the first stage of the reactive astrogliosis in vivo. In this
study, we demonstrated the involvement of PTEN in excitotoxicity through its
pharmacological inhibition by dipotassium bisperoxo (picolinato) oxovanadate
[bpv(pic)] in a model of temporal lobe epilepsy, obtained by intraperitoneal injection
of kainate in 2-month-old C57BL/6J male mice. We have demonstrated that
inhibition of PTEN by bpv(pic) rescues neuronal death and decreases the reactive
astrogliosis in the CA3 area of the hippocampus caused by systemic administration
of kainate. Moreover, the neurotoxin administration increases significantly the
scanty presence of mitochondrial PTEN that is significantly decreased by the
administration of the inhibitor 6 hr after the injection of kainate, suggesting a role of
PTEN in mitochondrial apoptosis. Taken together, our results confirm the key role
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played by PTEN in the excitotoxic damage and the strong anti-inflammatory and
neuroprotective potential of its inhibition.
Introduction
The phosphatase and tensin homolog deleted on chromosome ten (PTEN) was
initially studied extensively for its fundamental role in tumorigenicity: therefore,
the multiple functions performed by PTEN in Central Nervous System (CNS) in
both physiological and pathological conditions were initially underestimated and
became the focus of several studies only recently. In the CNS, PTEN plays a
fundamental role in development [1, 2, 3], synaptogenesis and synaptic plasticity
[4, 5] and in neuronal death [6].
PTEN gene encodes for a phosphatase specific for both protein and lipid
substrates [7, 8]. Both these activities can be involved in the regulation of neuronal
death [6, 9]. As a lipid phosphatase, PTEN directly antagonizes the PI3K/AKT
pathway which regulates growth, proliferation, survival, apoptosis and cell
migration as well as the development and maintenance of the nervous system
[10, 11]. Cultured hippocampal neurons, in which PTEN activity was decreased by
overexpression of a dominant-negative mutant form of PTEN, showed an increase
in the level of p-Akt (the active form of Akt) and, similarly to the neurons in mice
with PTEN haploinsufficiency (PTEN+/2 mice), exhibited increased resistance to
death induced by excitotoxicity [12]. As a protein phosphatase, PTEN regulates
the function and surface expression of N-methyl-D-aspartate receptors
(NMDARs), a key subtype of excitatory glutamate receptor known to mediate
excitotoxicity-induced neuronal death [9]. However, despite the fundamental
proapoptotic role played by the lipid and protein phosphatase activities, the
regulation of neuronal death by PTEN appears much more complex. In fact it has
been demonstrated that a death stimulus may also result in a subcellular
redistribution of PTEN that, in normal conditions localized in the cytosol,
translocates into mitochondria in cultured hippocampal cells treated with
staurosporine (a relatively nonselective protein kinase inhibitor that can induce
apoptosis in a broad spectrum of cells), suggesting the involvement of PTEN in
mitochondria-dependent apoptosis [13]. Moreover, elevated levels of mRNA and
PTEN protein have been shown in human Alzheimer’s Disease (AD), where they
contribute to the AD neurodegeneration [14], whereas other studies showed the
link between PTEN and stress activated signaling pathways such as c-Jun N-
terminal kinase (JNK) pathway [15]. Nevertheless, in spite of all these pieces of
evidence, the role of PTEN in regulating neuronal death is still far from being fully
understood.
To this aim, in our study we examined the effect of the pharmacological
inhibition of PTEN in a model of excitotoxic neuronal death induced by
intraperitoneal injection of kainic acid in mice.
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The excitotoxic damage is considered the major mechanism underlying
neuronal death in many human disease states such as ischemia, trauma and
epilepsy. The term indicates an excess of glutamate that, acting on metabotropic
and ionotropic excitatory receptors, causes cell death [16, 17]. As the glutamate,
kainic acid (KA) is able to trigger excitotoxic neuronal death [18]. In rodents,
systemic or intracerebral injection of KA, activating the kainate subtype of
ionotropic glutamate receptors, results in sustained epileptic activity in the
hippocampus, followed by a selective pattern of neuropathology characterized by
a severe neuronal loss and by glial cell activation and similar to the human
temporal lobe epilepsy [19, 20]. Treatment with antagonists of excitatory amino
acids, the most common strategy to prevent excitotoxicity, has not proved
clinically viable [21]; therefore, new neuroprotective strategies are focused
downstream the excitatory amino acid receptors in order to target molecules in
signaling pathways controlling neuronal death. In this context, PTEN can be
considered as an ideal candidate for its involvement in neuronal damage and,
probably, in reactive astrogliosis [22].
Here we show that PTEN inhibition by intraperitoneal administration of
dipotassium bisperoxo (picolinato) oxovanadate [bpv(pic)] is able to partially
prevent the massive neuronal loss and the reactive astrogliosis in the CA3 area of
the hippocampus after systemic injection of kainic acid in C57BL/6J mice.
Moreover, in animals treated with bpv(pic) the increased PTEN presence in
mitochondria induced by kainic acid seems to be reduced 6 hours after the
excitotoxin application.
Materials and Methods
Ethics statement
All experimental procedures on live animals were performed according to the
European Communities’ Council Directive of 24 November 1986 (86/609/EEC)
and University of Torino’s institutional guidelines for animal welfare (DL 116/92),
authorization 17/2010-B (June 30, 2010) by Italian Ministry of Health; efforts
were made to minimize the number of animals used and their suffering. The
project was approved by the bioethic committee of the University of Torino
(http://www.unito.it/unitoWAR/page/istituzionale/ricerca1/Ricerca_comitato1).
Experimental animals
2-month-old C57BL/6J male mice (weight 20 g) were purchased from Janvier, St
Berthevin Cedex, France. Animals had free access to food and water.
Mice were divided in 7 experimental groups (n54 for each group). Controls
were injected with three intraperitoneal injections of 0.9% saline. Three groups of
mice were treated with kainate and with two injections of 0.9% saline 30 minutes
before and 90 min after stimulation with kainate and sacrificed at different time
points after kainate injection (3, 6 or 12 h). Three groups received intraper-
PTEN Inhibition in Excitotoxicity
PLOS ONE | DOI:10.1371/journal.pone.0114554 December 12, 2014 3 / 20
itoneally kainate injection and two injections of bpv(pic) 30 minutes before and
90 minutes after the kainate stimulation and were sacrificed at different time
points after kainate injection (3, 6 or 12 h).
Other three experimental groups were used for Nissl-staining analysis and for
immunohistochemical analysis: (i) kainate-treated, 1 day survival (n53)
intraperitoneally injected with kainate and with two injections of 0.9% saline 30
minutes before and 90 minutes after stimulation with kainate; (ii) kainate/
bpv(pic)-treated, 1 day survival (n53) intraperitoneally injected with kainate and
with two injections of bpv(pic) 30 minutes before and 90 min after stimulation
with kainate; (iii) control animals, 1 day survival (n53) intraperitoneally injected
with three injections of 0.9% saline at the same time points of the kainate and
kainate/bpv(pic) animals.
Induction of epileptic seizures and bpv(pic) administration
We induced epileptic seizures by intraperitoneal (i.p.) injection of 25 mg/kg
kainate (Tocris Bioscience, Bristol, UK). Within one hour after administration of
kainate, mice showed the first symptoms (immobility, facial myoclonus and head
nodding), and only animals that reached the fifth stage of the Racine scale [19, 23]
were included in the study: stage 0, no seizures; stage 2, head nodding; stage 3,
forelimb clonus; stage 4, rearing in addition to severe forelimb clonus; stage 5,
rearing and falling in addition to severe forelimb clonus. To minimize suffering
and prevent mortality, 1 h following the onset of seizure, a single rectal
administration of 8 mg/kg diazepam (Valium; Roche, Monza, Italy) blocked
epileptic seizures within 30 min of administration. ALX-270-205-M005 bpV(pic)
PTP inhibitor (2 mg/kg, Vinci-Biochem, Vinci, Italy), the PTEN inhibitor, was
injected 30 minutes before and 90 minutes after stimulation with kainate. The
dose of PTEN inhibitor (2 mg/kg) was chosen on the basis of previous studies by
Sury and co-workers [24].
Tissue preparation
Animals were killed with an overdose of anesthetic (i.p. chloral hydrate) and
perfused through the left ventricle with washing phosphate buffer (0.1 M,
pH 7.4), followed by 4% paraformaldehyde in phosphate buffer. Brains were
removed from the skull and postfixed in the same fixative for 4 h. The tissue was
cryoprotected by immersion in buffered 30% sucrose overnight, embedded, and
frozen in cryostat medium (Bio-Optica, Milan, Italy). The brains were cut into
coronal, 20 mm thick, free-floating sections, and stored in a cryoprotective
solution at 220 C˚ until being used for Nissl-staining and for immunohisto-
chemical analysis.
Other animals were decapitated in deep anaesthesia. Just cut the heads of the
mice, the brains were dissected and the hippocampus (both sides) was quickly
removed, frozen and stored at -80 C˚ until being used for Western Blotting
analysis.
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PLOS ONE | DOI:10.1371/journal.pone.0114554 December 12, 2014 4 / 20
Total protein isolation from mouse hippocampi
Mouse hippocampi (both sides, n53) were collected and stored at 280 C˚
immediately after dissection from the brain. They were homogenized in RIPA lysis
buffer supplemented with proteases (16 complete protease inhibitor cocktail,
CPIC, Roche) and phosphatases (16 4-nitrophenyl phosphate 4-NPP, Roche)
inhibitors. Soluble fractions were prepared by centrifuging the total homogenates
at 13,000 rcf for 10 min; the supernatant was collected and used for Western blot
analysis. The total protein content was measured with the Bio-Rad Protein Assay
kit (Bio-Rad) and loaded on a pre-cast mini-gel system with 4-12% Bis-Tris
gradient to evaluate the phosphorylation status of Akt.
Mitochondria and cytoplasm protein isolation
All subsequent steps were conducted at 4 C˚. Proteins from both the cytosolic and
mitochondrial fractions were extracted according to the multiple centrifugation
method described elsewhere [25] which was slightly modified. Briefly,
hippocampal tissue was washed twice with ice-cold PBS and gently dounced 10
times in ice-cold isolation medium (250 mM Mannitol, 20 mM Tris, 1 mM
EGTA, 1 mM EDTA and 0.3% w/v BSA plus 1% phosphatase inhibitor and
protease inhibitor). The homogenates were stored on ice for 20 min and then
centrifuged at 450 g for 10 min. The supernatants were transferred into
centrifugation tubes. The subsequent centrifugation (22,000 g for 10 min)
generated the cytosolic fraction and the mitochondrial pellet. The pellet was
washed twice with isolation medium and then re-suspended in a denaturing lysis
buffer (250 mM NaCl, Tris 20 mM, EDTA 3mM, EGTA 3 mM, Nonidet 0.5%,
1% phosphatase inhibitor and protease inhibitor) and incubated on ice for
30 min. Thereafter, the mitochondrial suspension was briefly sonicated and
centrifuged to remove insoluble material (16,000 g for 15 min). Supernatants
were normalized for cytosolic and mitochondrial proteins content (Bio-Rad
Protein Assay kit; Bio-Rad) and stored at 280 C˚.
Quantitative analysis
Neuronal cell counts were performed in CA3 area, in Nissl-staining coronal
sections corresponding to plates 41, 44, 47 of the Paxinos and Franklin atlas [26],
representing three different levels of the hippocampus, from rostral to caudal side,
in order to consider 3 sections/mouse.
Neurons were identified morphologically by their large pale nuclei, bearing a
prominent nucleolus, surrounded by an intensely stained cytoplasm. Glial cells
(astrocytes, oligodendrocytes and microglia) were identified by their smaller
nuclei and little cytoplasm and were not included in cell counts. Nissl-stained
slides were quantitatively analyzed under a Nikon Eclipse 600 light microscope,
using a motorized stage interfaced with the computer. The density of surviving
neurons at one day from kainate injection, expressed as cells/mm, was obtained at
40x, counting nucleoli of the neurons by the use of the Neurolucida software
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program for computer-aided microscopy (Microbrightfield Inc., Williston, VT).
Cells were counted on the computer screen using an Optronics MicroFire digital
camera mounted on a Nikon Eclipse E600.
Immunohistochemistry
Immunofluorescence staining for GFAP, P-c-Jun, neuron-specific nuclear protein
(NeuN), PTEN, cleaved caspase-3 and MAP-2 was performed in the oriens,
radiatum and pyramidale stratum of the CA3 hippocampus area 24 h after kainate
stimulation. After blocking non-specific binding sites for 30 min at room
temperature with 0.3% Triton X-100 and 10% normal donkey serum (Sigma-
Aldrich) in phosphate buffered saline (pH 7.4), the sections were incubated with
the primary antibodies in the same solution at 4 C˚: 1:80 polyclonal rabbit anti P-
c-Jun (Abcam, Cambridge, UK) together with 1:200 monoclonal mouse anti
NeuN (Millipore); 1:500 mouse anti GFAP antibody (Cell Signaling, Plymouth,
PA, USA); 1:200 mouse anti PTEN antibody (Santa Cruz); 1:300 polyclonal rabbit
anti cleaved caspase-3 antibody (Cell Signaling Technology Inc., Danvers, MA)
together with 1:200 monoclonal mouse anti Microtubule-Associated Protein 2
(MAP-2, Millipore).
The polyclonal rabbit anti P-c-Jun antibody (Abcam, Cambridge, UK, Cat
No. ab30620) was obtained by immunizing a rabbit with a synthetic phospho-
peptide derived from human c-Jun around the phosphorylation site of serine 73.
This antibody detects c-Jun only when phosphorylated at serine 73 (manufac-
turer’s information obtained in human breast carcinoma and extracts of UV-
treated Hela cells).
The monoclonal anti NeuN antibody (Millipore, Cat No. MAB377, clone A60)
specifically recognizes the DNA-binding, neuron-specific protein NeuN.
The monoclonal mouse anti GFAP antibody (Cell Signaling, Plymouth, PA,
USA, Cat No. 3670) detects endogenous levels of total GFAP protein and was
obtained by immunizing animals with native GFAP purified from pig spinal cord.
The monoclonal mouse anti PTEN antibody (Santa Cruz Biotechnology, Cat
No. sc-7974, clone A2B1) was raised against amino acids 388-400 of PTEN of
human origin.
The polyclonal anti cleaved caspase-3 (Asp175) is produced by immunizing
animals with a synthetic peptide corresponding to amino-terminals residues
adjacent to (Asp175) in human caspase-3 (Cell Signaling, Cat No. 9661).
The monoclonal mouse anti MAP-2 antibody (Millipore, Cat No. MAB 3418,
clone AP20) is produced by immunizing animals with bovine brain microtubule
protein.
After rinsing, primary antibodies were detected by incubating sections for one
hour at room temperature in 1:200 Cy3-coniugated donkey anti-rabbit IgG (H+L)
(Jackson Immuno Research Laboratories, West Grove, PA, USA) or in 1:100 Cy2-
coniugated donkey anti-mouse IgG (H+L) (Jackson Immuno Research
Laboratories). Sections were counterstained by incubation with DAPI (4,6-
Diamidino-2-phenyindole, dilactate; Sigma) diluted 1:10 in PBS 0.3% Triton X-
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100 for 10 minutes at room temperature after immunohistochemical labelling.
Controls included sections treated with secondary antibody alone, which did not
show appreciable staining. The percentage of the total area in the CA3 layers that
was GFAP or P-c-Jun-positive was quantified using the Image j NIH software for
Windows (Bethesda, MA, USA).
Western blot analysis
Proteins in total homogenates and in cellular fractions (mitochondria and
cytosol) were determined using the Bio-Rad protein assay kit. Total cell proteins
or proteins of the distinct subcellular fractions were separated on pre-cast mini-
gel system with 4–12% Bis-Tris gradient (NuPAGE electrophoresis system from
Invitrogen) with MES running buffer. Separated proteins were transferred
electrophoretically onto nitrocellulose membranes. Equal protein loading was
confirmed by Ponceau S staining. After the blocking of nonspecific binding sites
with Tris-buffered saline-Tween (t-TBS; Tris, 0.02 M, NaCl, 0.150 M and Tween
20, 0.1%) containing 1% non-fat dried milk, nitrocellulose membranes were
incubated with specific primary antibodies and the immune complexes were
detected using appropriate peroxidase conjugated secondary antibodies and
enhanced chemiluminescent detection reagent ECL (Pierce). The blots were
stripped and used for sequential incubation with control antibodies.
Densitometric analysis was carried out on the Western blots using the Quantity
one software. The pixel intensity for each region was analysed, the background
was subtracted and the protein expressions were normalized to loading control for
each lane.
From total cell proteins the phosphorylation status of Akt has been evaluated
incubating the nitrocellulose membrane with primary antibodies against p-Akt
(1:200 in milk, Santa Cruz) and Akt (1:200 in milk, Santa Cruz) in order to
calculate the ratio p-Akt/Akt. The immune complexes were detected using as the
secondary antibody the Stabilized Goat Anti-Rabbit HRP-Conjugated by Pierce.
Anti-Mouse GAPDH (1:1000, Millipore) was used as control of loading.
Blots from mitochondrial and cytosolic fraction were incubated with anti-
mouse PTEN (1:500 in milk, Santa Cruz). The immune complexes were detected
using as the secondary antibody the Stabilized Goat Anti-Mouse HRP-Conjugated
by Pierce (1:1000 in milk). As loading control it has been used anti-mouse
GAPDH for cytosolic fraction (1:1000 in milk, Millipore) and anti-rabbit
HADHA for mitochondrial fraction (1:5000 in milk, Abcam).
The polyclonal anti p-Akt antibody (Santa Cruz Biotechnology, Cat No. sc-
7985-R) was raised in rabbit against a short amino acid sequence containing
phosphorylated Ser 473 of Akt1 of human origin.
The polyclonal anti Akt antibody (Santa Cruz Biotechnology, clone H-136, Cat
No. sc-8312) was raised in rabbit against amino acids 345-480 of Akt1 of human
origin.
These antibodies can recognize bands at 56 and 62 kDa.
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The monoclonal anti-PTEN antibody (Santa Cruz Biotechnology, clone A2B1
Cat No. sc-7974) was raised in mice against amino acids 388–400 of PTEN of
human origin and recognizes a single band of 55 kDa.
The monoclonal anti Glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
antibody (Millipore, clone 6C5, Cat No. MAB374) was obtained by immunizing a
mouse with Glyceraldehyde-3-phosphate dehydrogenase from rabbit muscle. This
antibody recognizes a single band of 38 kDa.
The polyclonal rabbit anti HADHA antibody (Abcam, Cat No. ab54477) was
obtained by immunizing a rabbit with a synthetic peptide derived from human
surrounding amino acid 750. This antibody detects a single band of approximately
83 kDa.
Statistics
Statistical analysis was performed with GraphPad PRISM 5. Values shown
represent the mean ¡ SEM of at least three separate experiments. Data were
compared with One-way or Two-ways ANOVA followed by Tukey’s test or
Bonferroni post hoc test. Differences were considered to be significant when
P,0.05.
Results
1. Epiletic seizures
In this study we studied kainate (KA) acid-treated animals that showed seizures
corresponding to the fifth degree of the Racine scale. The few animals that did not
reach this degree of the scale were excluded from the study. Systemic
administration of KA resulted in the death of approximately 15% of the animals
(data not shown). As expected, the systemic inhibitor administration does not
affect animal behavior (data not shown). By Western Blotting analysis we have
shown that PTEN inhibitor is able to increase the level of phosphorylated Akt, the
major downstream target of PTEN, in the hippocampus 6 hours after kainate
stimulation compared to the administration of kainate alone. These data
confirmed that the bpv(pic) dose is appropriate and inhibits PTEN activity in this
model (S1 Figure).
2. Morphological changes in the CA3 area in the hippocampus
Since it has been reported that systemic injection of KA resulted in a selective
hippocampal neurodegeneration, especially in the CA3 area [27] for the highest
density of KA receptors, we focused our analysis on this area. One day after KA
stimulation, the thickness of the pyramidal cell layer in the CA3 was markedly
decreased (Fig. 1B) compared to the control (Fig. 1A) whereas the application of
PTEN inhibitor partially prevented the thinning of CA3 (Fig. 1C). Besides, as a
consequence of the treatment with kainate, we also observed degenerating
neurons with condensed nuclei that can be considered signs of apoptotic cell
PTEN Inhibition in Excitotoxicity
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death in the CA3 area (see Fig. 1B1) as demonstrated by double immunofluor-
escence for MAP-2 (Microtubule-associated protein 2), a neuronal marker, and
cleaved caspase-3, a marker of apoptosis, clearly expressed in neurons in the CA3
area after kainate treatment (Fig. 1D).
3. Quantitative analysis of hippocampal cell loss in the CA3 area
Subsequently, to determine the susceptibility of the hippocampal CA3 subfield to
KA stimulus, we counted neurons in this area in Nissl-stained coronal sections.
These sections represent three different levels of the hippocampus, from rostral to
the caudal, corresponding to plates 41 (Bregma 1.22 mm), 44 (Bregma 1.58 mm)
and 47 (Bregma 1.9 mm) of the Paxinos and Franklin atlas [26]. After 24 h,
kainate stimulus resulted in a decrease of the pyramidal cell density, partially
prevented by bpv(pic) treatment. This tendency, present at all considered levels, is
statistically significant in the intermediate level (Two way ANOVA and
Bonferroni post hoc analysis, P,0.01 control (ctr) vs kainate (KA); P,0.01
kainate (KA) vs kainate and PTEN inhibitor (KA+I)) (Fig. 1E).
4. GFAP immunofluorescence
Data in the literature showed the involvement of PTEN in the first stage of
reactive astrogliosis in vivo [22]. To explore this issue in our experimental design,
we quantified the GFAP density of immunofluorescent reaction in the stratum
oriens, radiatum and pyramidale of the CA3 hippocampus area 24 h after kainate
stimulation (Fig. 2A,B,C). Two-way ANOVA statistical analysis revealed that the
administration of kainate as well as that of the inhibitor causes the same effects on
the density of GFAP in all the 3 considered layers. Therefore we evaluated the
effects of kainate on the whole CA3: 24 h after stimulus application, the density of
GFAP positive profiles was significantly increased compared to the control
animals which received saline (One way ANOVA and Turkey post hoc analysis,
P,0.05 ctr vs KA). PTEN inhibition by bpv(pic) resulted in a significant decrease
in GFAP fluorescence density compared to kainate, almost the same density as in
the control (One way ANOVA and Turkey post hoc analysis, P,0.05 KA vs KA+I;
P5ns ctr vs KA+I) (Fig. 2D).
Fig. 1. PTEN inhibition protects CA3 neurons from kainate-induced excitotoxicity. Nissl-staining of
hippocampus sections of mice treated with saline (A, control), with kainate (B, KA) or with both kainate and
bpv(pic) (C, KA+I), killed one day after treatment (scale bar: 1 mm). A1. CA3 area of control animals (ctr)
treated with saline only (scale bar: 50 mm). B1. CA3 area of animals treated with kainate (KA). Arrowheads
point to apoptotic bodies and condensed nuclei as a consequence of kainate treatment. At higher
magnification, a neuron that is degenerating. C1. CA3 area of animals treated with both kainate and PTEN
inhibitor (KA+I). D. Immunostaining showing cleaved caspase-3 (in red) in neurons labeled with MAP-2 (in
green) in the CA3 area of the hippocampus, one day after kainate administration. At higher magnification,
arrowheads indicating neurons with a clear expression of cleaved caspase-3. Scale bar: 50 mm (30 mm at
higher magnification). E. Surviving neurons in the hippocampal CA3 region. Histogram showing the linear
density (cells/mm) of surviving neurons in the CA3 area of the hippocampus one day following kainic (KA) acid
injection or kainic (KA) acid injection and PTEN inhibition (I) by bpv(pic) (KA+I). **P,0.01, 11P,0.01.
doi:10.1371/journal.pone.0114554.g001
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5. P-c-Jun immunofluorescence
Zhang and co-workers [15] revealed the presence of a link between PTEN and
JNK signaling pathways, in a model of in vivo ischemic damage. According to this
finding, we hypothesized that PTEN inhibition could affect the phosphorylation/
activation status of c-Jun, a downstream nuclear target in the JNK pathway. As for
GFAP, we measured the P-c-Jun density in immunofluorescent reaction in the
nuclei of neurons in the stratum oriens, radiatum and pyramidale of the CA3,
24 h after kainate stimulation (Fig. 3A,B,C).
Also in this case, Two-way ANOVA statistical analysis showed that the
administration of kainate as well as that of the inhibitor causes the same effects on
Fig. 2. Astrogliosis in the CA3 area of the hippocampus following kainic acid injection. Glial fibrillary acidic protein (GFAP)-positive profiles in the
hippocampi of control (A), kainic acid (KA)-treated, 1 day survival mice (B) and KA/bpv(pic)-treated, 1 day survival mice (C) (scale bar: 50 mm). D. Histogram
showing the % of GFAP staining in the hippocampal CA3 area one day after kainic acid injection and PTEN inhibition by bpv(pic). The significant increase in
GFAP immunoreactivity after kainate administration, expressed as a percentage of the whole area occupied by positive profiles, is significantly prevented by
bpv(pic) treatment. *P,0.05, 1,0.05.
doi:10.1371/journal.pone.0114554.g002
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the density of P-c-Jun immunofluorescence in all the 3 considered layers.
Therefore we considered the effects of kainate on the whole CA3: after 24 h from
stimulus application, the fluorescence density of P-c-Jun was significantly
increased compared to the control animals treated with saline (One way ANOVA
and Turkey post hoc analysis, P,0.05 ctr vs KA) (Fig. 3E). Double immuno-
fluorescence for P-c-Jun and for neuron-specific nuclear protein (NeuN), a
Fig. 3. Activation of c-Jun after kainate stimulation in the CA3 area of the hippocampus. The P-c-Jun
immunoreactivity, absent in control mice (A), can be observed in neurons of animals treated with kainate (B) or
with both kainate and PTEN inhibitor (C), sacrificed one day after the treatment. At higher magnification,
nuclei of neurons positive for P-c-Jun after kainate treatment. D. Immunostaining showing that P-c-Jun (red) is
revealed in the nucleus of neurons labeled with NeuN (green) in the CA3 area of the hippocampus, one day
after the kainate stimulation. Scale bar: 50 mm. E. Histogram showing the % of P-c-Jun staining in
hippocampal CA3 subfield one day following KA injection and PTEN inhibition by bpv(pic). As it can be
observed, bpv(pic) is unable to prevent the significant increase in the P-c-Jun immunoreactivity caused by
kainate treatment. *P,0.05.
doi:10.1371/journal.pone.0114554.g003
PTEN Inhibition in Excitotoxicity
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neuronal marker, revealed a colocalization of the two markers in the same cells,
indicating that P-c-Jun immunoreactivity was localized in neurons as shown in
Fig. 3D. Surprisingly PTEN inhibition by bpv(pic) did not result in a decrease in
the fluorescence density of P-c-Jun compared to the kainate (One way ANOVA
and Turkey post hoc analysis, P5ns KA vs KA+I; P5ns ctr vs KA+I) (Fig. 3E).
6. PTEN immunofluorescence
PTEN-positive profiles were found in CA3 of the hippocampus in the saline
controls (Fig. 4A) and one day after kainate stimulation (Fig 4B).
7. Mitochondrial translocation of PTEN after the excitotoxic
stimulus
As already mentioned, a death stimulus may also result in a subcellular
redistribution of PTEN compared to the physiological status. For example, in
cultured hippocampal cells stimulated by staurosporine, PTEN displayed a
mitochondrial accumulation [13]. By Western Blotting analysis we evaluated if a
mitochondrial translocation of PTEN also occurred in our model of in vivo
kainate excitotoxicity.
We evaluated the mitochondrial PTEN 3, 6 and 12 h after kainate stimulation:
a significant increase in mitochondrial accumulation of PTEN occurred 6 and
12 h after kainate systemic administration compared to the control animals
treated with saline (Two way ANOVA and Bonferroni post hoc test P,0.01 ctr vs
KA 6 h; P,0.05 ctr vs KA 12 h). A significant decrease in mitochondrial PTEN
levels seems to be 6 h after the application of the excitotoxic stimulus in animals
treated with PTEN inhibitor (Two way ANOVA and Bonferroni post hoc test
P,0.05 KA 6 h vs KA+I 6 h) but this effect was no longer visible 12 h after the
application of kainate (Two way ANOVA and Bonferroni post hoc test P5ns KA
12 h vs KA+I 12 h) (Fig. 5A-B).
On the contrary, in the cytosolic fraction, PTEN levels did not show significant
differences after kainate stimulation or PTEN inhibition in any time point
considered (Fig. 5C-D).
Discussion
Although excitotoxicity is considered as the major mechanism regulating
neuronal death in many human disease states, an effective neuroprotective
strategy against excitotoxicity is still far. The most common neuroprotective
strategy consisting in blocking excitatory aminoacid NMDA receptors, although it
proved neuroprotective, leads also to the inhibition of pathways necessary for
normal neuronal function and survival, generating many adverse side effects
[28, 29, 30, 31]. These findings suggest the necessity to intervene at an
intermediate level in the excitotoxic cascade, targeting molecules downstream of
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the calcium entry but upstream the level where it is impossible to block neuronal
death, in order to prevent the inhibition of physiological functions.
To this aim the phosphatase and tensin homolog deleted on chromosome 10
(PTEN), initially known as tumor suppressor factor, can be considered as an ideal
candidate. Several studies proved its key role in regulating neuronal death and the
neuroprotective value of its downregulation/inactivation: neurons from PTEN
heterozygous mice exhibited increased resistance to death induced by over-
activation of glutamate receptors [12]; pretreatment with bpv(pic), a potent
PTEN inhibitor or by intra-cerebroventricular infusion of PTEN siRNA reduced
the infarct volume in a male rat model of middle cerebral artery occlusion [6];
PTEN downregulation by a specific antisense oligonucleotide or by siRNA
significantly inhibited the elevated production of reactive oxygen species, a key
event in neurodegenerative processes, and the neuronal death in in vitro models of
stroke and Parkinson’s disease [32]; recently, elevated levels of PTEN mRNA and
protein have been shown in human Alzheimer’s Disease (AD) where they
contribute to neurodegeneration [14].
Traditionally it is thought that PTEN regulates neuronal death through its lipid
phosphatase activity, directly antagonizing the prosurvival PI3K/AKT signaling
pathway [10, 11] although, recently, additional PTEN dependent mechanisms as
the poor characterized PTEN phosphatase activity [9], different PTEN subcellular
localizations [13, 33, 34] and the link with excitotoxic signaling pathways, such as
c-Jun N-terminal kinase cascade, are emerging [15]. However, despite the several
studies on the role of PTEN in neuronal death, its complex mechanisms have not
yet been completely clarified.
The aim of this work was to study the role of PTEN in excitotoxic damage in a
model of murine temporal lobe epilepsy obtained by intraperitoneal injection of
kainic acid. Systemic or intracerebral injection of kainate results in sustained
epileptic activity in the hippocampus, similar to human temporal lobe epilepsy
Fig. 4. PTEN expression in the CA3 area of the hippocampus. Immunofluorescence showing PTEN
expression in the CA3 area 1 day after kainic acid i.p. injection (B) and in control mice treated only by saline
(A). Nuclei were stained with nuclear marker DAPI. Scale bar: 50 mm.
doi:10.1371/journal.pone.0114554.g004
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Fig. 5. PTEN expression in mitochondrial and cytosolic fraction after the excitotoxic stimulus.
Representative Western blot (A) and relative quantification (B) showing mitochondrial PTEN translocation in
control (ctr), kainic treated group (KA) and kainic/bpv(pic) group (KA+I) 3, 6 and 12 h after the kainate
treatment. As it can be observed, the excitotoxic stimulus leads to a significant increase in mitochondrial
PTEN expression, significantly decreased 6 h after kainic acid injection in animals treated with bpv(pic). On
the contrary, in the cytosolic fraction kainic acid or PTEN inhibitor does not lead to significant differences in
PTEN levels in any time points considered as it can be observed from representative Western blots (C) and
relative quantification (D). Data are expressed as mean ¡ S.E.M., *P,0.05, #P,0.05, **P,0.01 with Two
way ANOVA and Bonferroni post hoc test. Experiments were repeated three times.
doi:10.1371/journal.pone.0114554.g005
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with an important neuronal loss in the hilus, in the CA1 and in the CA3 area of
the hippocampus [35] and with the activation of microglia and astrocytes in the
hippocampal lesions [36, 37].
The involvement of PTEN in the kainate excitotoxic damage is proved
inhibiting PTEN with two intraperitoneal injections of bisperoxovanadate
bpV(pic), 30 minutes before and 90 minutes after stimulation with kainate. We
observed that one day after kainate stimulation, the thickness of the pyramidal cell
layer in the CA3 area was markedly decreased compared to the control, in
agreement with the significant reduction in pyramidal neuronal density resulting
from the stereological counts at three different levels of the hippocampus in the
same area. As expected, PTEN inhibition by bpv(pic) resulted in a rescue of the
pyramidal neuronal loss in the CA3 area in all the tree considered hippocampus
levels.
Challenging with kainate leads also to astrogliosis, the activation process of
astrocytes characterized by hypertrophy and by the upregulation of intermediate
filaments composed of nestin, vimentin, and glial fibrillary protein (GFAP) and by
the activation of cell proliferation [38, 39]. The reactive astrocytes migrate towards
the injured area to constitute the glial scar, and release factors mediating the tissue
inflammatory response and remodeling after lesion [40, 41] although when
neuronal damage is irreversible, microglia and astrocytes start secreting toxins
rather than trophic factors, thus exploiting neuronal damage [42, 43]. The
presence of kainate receptors on astrocytes leads to their activation thirty minutes
after kainate injection [36, 37]; at the same time PTEN appears weakly expressed
in immature astrocytes. Decreased PTEN expression in highly activated astrocytes
showing extensively spindled shape seven days after kainic acid injection,
suggested that PTEN could have a role mainly in the early stage of reactive
astrogliosis in vivo [22]. As expected, treatment with kainic acid has considerably
increased the presence of mature astrocytes whereas the application of PTEN
inhibitor, resulting in a decrease in the levels of GFAP expression compared to the
mice treated only with kainate, seems to be opposed to the process of astrocytes
maturation/activation. Therefore, using a reactive gliosis model by systemic
injection of kainic acid in mice we confirmed that PTEN has a role in the early
stage of reactive astrogliosis in vivo and with further analysis we could explain
what this entails in terms of neuroprotection or neurodegeneration. In fact,
providing all this evidence, we have only underlined the crucial role of PTEN in
excitotoxicity once again without investigating the molecular mechanisms in
which it is involved.
As known, the c-Jun N-terminal kinases (JNKs), belonging to the family of
mitogen-activated protein kinases (MAP-kinases), are key enzymes in the cellular
response to stress signals such as NMDA stimulation, Abeta fragments, hypoxia,
reactive oxygen species, ultraviolet radiations. Data from our lab showed the
involvement of JNK in excitotoxic neuronal death induced by intraperitoneal
injection of kainate in adult male Sprague-Dawley rats [44]. Other studies
underlined the link between JNK signaling pathway and PTEN so that the
activation of c-Jun N-terminal kinases 1/2 (JNK 1/2) is decreased after the specific
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downregulation of PTEN protein level and is associated to increased AKT
activation in ischemic damage [15]. This evidence suggested us to verify the effects
of PTEN inhibition on the phosphorylation/activation status of c-Jun, the
downstream target in JNK signaling cascade, evaluating the fluorescence density of
P-c-Jun in the neuronal nuclei of the CA3 area of mouse hippocampus. As
expected, treatment with kainate increased significantly P-c-Jun immunoreactivity
in the nuclei of the pyramidal neurons although the application of PTEN inhibitor
was not able to decrease the fluorescence density of P-c-Jun. Therefore we
hypothesize that PTEN and JNK signaling pathways, although both involved in
the kainate excitotoxicity, act independently from each other and PTEN regulates
the neuronal death through molecular mechanisms that do not include c-Jun as a
downstream target.
Through the proposed mechanisms of action, the different subcellular
localizations of PTEN assumed an increasing importance. In particular the
mitochondrial localization of PTEN in cultured hippocampal cells after
challenging with staurosporine seems to contribute to mitochondria-dependent
apoptosis as the knockdown of PTEN inhibited the staurosporine-induced
increase of cytochrome c release in the cytosol and the activation of caspase 3, key
features of apoptotic process [13]. Besides Bononi and co-workers showed that a
fraction of PTEN protein localizes to the endoplasmic reticulum and
mitochondria-associated membranes, signaling domains involved in the transfer
of calcium from the endoplasmic reticulum to the mitochondria and in the
apoptosis induction [45]. These pieces of evidence and the knowledge that in our
model recurrent seizures associated with the chronic phase of epilepsy lead to the
mitochondrial damage [46] suggested us to verify PTEN mitochondrial
accumulation after kainate stimulation. We performed Western Blotting analysis
3, 6 and 12 h after kainate stimulation revealing a mitochondrial accumulation of
PTEN that seems to be significantly reduced 6 hours after the excitotoxic stimulus
in animals treated with bpv(pic). This effect is no longer visible after 12 h,
probably due to the reversible binding between PTEN and its inhibitor.
To explain the presence of PTEN in mitochondria, it has been suggested a role
for PTEN as a mitochondrial carrier of Bax, a proapoptotic protein localized at
the mitochondrial membrane upon apoptosis induction. It has been proved that
Bax is physically associated with PTEN in the absence and in the presence of the
staurosporine apoptotic stimulus so as to suggest a role for PTEN in
mitochondrial damage and, consequently, in mitochondrial apoptosis [13].
In our model the fundamental role ascribed to PTEN in the massive neuronal
loss in the CA3 area of the hippocampus seems to be associated to the PTEN
mitochondrial translocation significantly reduced 6 h after kainate application in
animals treated with bpv(pic). Further analysis, such as the analysis of the
mitochondrial apoptotic pathway, will provide the evidence to support this
hypothesized role of PTEN in mitochondrial apoptosis.
The PTEN pathway plays a key role in excitotoxic cell death in our
experimental model of epileptic seizures in the hippocampus. Its blockade can
prevent both neuronal cell death and glial activation. The pathway is probably
PTEN Inhibition in Excitotoxicity
PLOS ONE | DOI:10.1371/journal.pone.0114554 December 12, 2014 17 / 20
independent of the JNK pathway. Therefore, they could act either in concert or in
alternative, but an efficient neuroprotective strategy should target several different
pathways of cell death to be more efficient in the translation from bench to
bedside.
Supporting Information
S1 Figure. Increase of p-Akt level by bpv(pic) administration. Histogram (B)
and images (A) showing Akt activation in protein total extracts of the
hippocampus 6 hours after kainate treatment. As it can be observed, PTEN
inhibition by bpv(pic) antagonizes kainate effect on Akt activation, increasing the
level of p-Akt, although not significantly (One way ANOVA and Turkey post hoc
analysis, P5ns KA vs KA+I; P5ns ctr vs KA; p5ns ctr vs KA+I).
doi:10.1371/journal.pone.0114554.s001 (TIF)
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